Sponsored
Arrivo BioVentures, which emerged from stealth mode less than two years ago with $49 million in funding and four drug candidates, has raised another $45 million and plans to advance its treatment focused on major depression disorder or MDD.
Sponsored
Results from a collaborative project between Tiamat Sciences and BIOMILQ — women-owned biotechnology startups in Research Triangle Park — show the promise of using plant-based proteins to lower the cost of producing food using cultured cells.
Sponsored
Duke Health is initiating the first phase of its Copilot deployment, focusing on empowering IT leaders and staff with training and experimental use cases to harness the transformative potential of generative AI. Take a look.
Sponsored
The “Intelligent Trials” technology focuses on the feasibility of studies, and providing diversity data to aid companies in meeting representative enrollment targets.
Sponsored
You could call SinnovaTek a Raleigh-based food technology company. But that would miss some significant nuances. Here’s why.
Sponsored
Startup biotech Propella Therapeutics is being acquired by Japan-based Astella Pharma in a deal valued at $175 million. Here are the details.
Sponsored
A Research Triangle Park-based biotechnology company working on a drug to treat strokes has raised $27.5 million from investors. Here are the details.
Sponsored
Avior Bio, a small Cary startup developing a treatment for pruritus, or chronic itchy skin, has secured an agreement to license its clinical-stage therapy to a New Jersey pharmaceutical company.
Sponsored
Climate tech company Natrx has been awarded a National Science Foundation (NSF) Small Business Innovation Research grant to continue development of its remote-sensing technology designed to quantify the economic value of carbon stock in coastal wetlands.
Sponsored
Grifols, a global leader in plasma medicines, has received approval from the U.S. Food and Drug Administration for its new immunoglobulin (Ig) purification and filling facility at its Clayton manufacturing campus, one of the world’s largest sites for producing plasma-derived medicines.
